Search
Cognition Therapeutics Inc
CGTXAdd to Watchlist
0.687USD
+0.052+8.19%
Close 11-06 16:00（ET）
65.33MMarket Cap
LossP/E TTM
Cognition Therapeutics Inc (CGTX) Stock Price Target & Forecast
Analyst Rating
Based on 3 analysts giving stock ratings to Cognition Therapeutics Inc in the past month.
Buy
0 Strong Buy
3 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
3.333USD+377.42%
CGTX Analyst Recommendation Trends
In the current month, CGTX has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CGTX average Analyst price target in the last month is 3.333.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
3
3
3
4
4
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
3
3
4
4
4
4
4
Financial Forecasting
Based on analysts' estimates, CGTX EPS is projected to reach -0.137 in FY2026Q4, following reported EPS of -0.040 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.07
-0.06
-0.07
-0.14
-0.05
Actual
-0.05
-0.04
-0.04
--
--
Surprise
+24.09%
+31.49%
+40.00%
--
--
FAQs
What is Cognition Therapeutics Inc's price target?
Analysts forecast that Cognition Therapeutics Inc's price target is USD 3.50, with the highest forecast at USD 4.00 and the lowest forecast at USD 2.00.
How have Cognition Therapeutics IncCGTX's recent earnings per share performed?
The market expectation was USD -0.04, while Cognition Therapeutics IncCGTX's earnings per share (EPS) for the previous quarter was USD -0.04. EPS for the next quarter is expected at USD -0.14.
What is the analyst rating for Cognition Therapeutics Inc?
Based on the ratings of Cognition Therapeutics Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.